Super Gonorrhea is back: Health Director discovers another 3 cases of antibiotic-resistant infections
- A woman in her twenties from London was diagnosed with a super bug, the health director said.
- A couple from Midlands, also in their twenties, turned out to be infected.
- Health director warned that it was premature to say whether tensions were widespread in Britain
Another three cases of certain antibiotic-resistant gonorrhea have been found in the United Kingdom, says the director of health.
In some cases LondonAn unidentified female in her twenties was found to have a superbug immune to ceftriaxone, the main antibiotic used to treat gonorrhea.
In Midland, a heterosexual couple in their twenties was also diagnosed with a sexually transmitted disease (STI) resistant to the drug.
UK health and safety officials said the patient had an infection last month and was receiving alternative treatment.
The United Kingdom recorded four ceftriaxone-resistant gonorrhea infections three months after a man from London in his twenties was diagnosed with ceftriaxone-resistant infection in November. It was cleared with other treatments.
Dr. Katy Sinka, an epidemiologist of UKHSA sexually transmitted diseases, said it was “too early to say” whether gonorrhea resistant to this antibiotic is widespread in the country.
An unidentified woman in her twenties from London and a heterosexual couple from Midlands, also in her twenties, were diagnosed with Super Bug Co., Ltd.
Gonorrhea is the second most common sexually transmitted disease (STI) in the United Kingdom and spreads through unprotected sex.
People infected with bacteria tend to have dark green or yellow secretions from their vagina and penis and feel pain when urinating.
If left untreated, the disease can cause serious complications such as infertility and potentially life-threatening pelvic inflammatory disease in women. In pregnant women, it can also cause permanent blindness in newborns.
Antibiotics to treat gonorrhea are given orally or by injection into the thighs or buttocks, and the symptoms usually go away after a few days.
Cases of mutant strains resistant to ceftriaxone are increasing in the Asia-Pacific region.
The UKHSA stated that incidents in the United Kingdom were usually “people who visited or emigrated to the United Kingdom from this area.”
Dr. Shinka added:
“It’s too early to say if this is the beginning of a long-term trend, but we know that sexually transmitted diseases are generally on the rise.”
The UKHSA issued a warning in 2018 after it was discovered that a British man was infected with gonorrhea, which is resistant to both ceftriaxone and azithromycin.
Men had regular sex with females in the UK, but they said they were infected with this strain after a one-time encounter with females in Southeast Asia.
The man told his doctor that the symptoms of gonorrhea began a month after the encounter.
This was the first case in which an infection resistant to both antibiotics was recorded.
The patient was treated with the third antibiotic, ertapenem, before the case was resolved.
British doctors were prescribing the antibiotic ciprofloxacin to treat gonaditis infections.
However, in 2005, the bacteria became resistant and were no longer recommended as a possible treatment.
Nevertheless, according to official analysis, doctors were prescribing drugs to treat infections by 2011.
Another antibiotic, cefixime, was also discontinued in 2011 for the treatment of gonorrhea after the bacteria became resistant to gonorrhea.
The chief doctor had previously warned that the disease could soon become incurable.
advertisement
